 |
|
|
| |
Long-term Safety and Efficacy of
Emtricitabine/Tenofovir Alafenamide (F/TAF)
With a
Third Agent in Children Living With HIV
|
| |
| |
AIDS 2022 July 29-Aug 1 Montreal
Renate Strehlau,1 Jaime G. Deville,2 Chrisna Andersen,3 Elizabeth McFarland,4 Janet S. Chen,5 Shirley Li,6 Heather Maxwell,6 Vinicius A. Vieira,6 Kathryn Kersey,6 Elizabeth Castaño,7 Mark F. Cotton8
1Wits VIDA-Nkanyezi, University of the Witwatersrand, Johannesburg, South Africa; 2UCLA David Geffen School of Medicine, Los Angeles, California, USA; 3Be Part Yoluntu Centre, Paarl, South Africa; 4University of Colorado School of Medicine, Children’s Hospital Colorado, Aurora, USA;
5Drexel University College of Medicine, Philadelphia, Pennsylvania, USA; 6Gilead Sciences, Inc., Foster City, California; 7Hospital del Niño, Ciudad de Panamá, Panamá; 8Family Centre for Research with Ubuntu (FAMCRU), Stellenbosch University, Cape Town, South Africa
|
| |
|
|
|
|
|
